• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

June 21, 2011

View Archived Issues

New clinical data presented on brentuximab vedotin

Read More

Selective ROCK-2 inhibitors presented by University of Michigan

Read More

Targeted secretion inhibitors SXN-101000 and SXN-101742 inhibit growth hormone secretion in vivo

Read More

Aliskiren shows efficacy in children with hypertension

Read More

New GPR119 receptor agonists claimed by Pfizer

Read More

Researchers at GSK present new antimalarial agents

Read More

Novel muscarinic acetylcholine M1 receptor modulators disclosed

Read More

Merck KGaA presents new HSP 90 inhibitors

Read More

Cubist Pharmaceuticals reports phase II data on CXA-201 and CB-183315

Read More

FDA committee recommends approval of VEGF Trap-Eye for wet AMD

Read More

Photocure begins enrolling women with CIN due to HPV infection in phase II Cevira trial

Read More

Yeast-based vaccine GI-6207 is safe in phase I trial in metastatic cancer expressing CEA

Read More

Fostamatinib disodium improves quality of life in subjects with active rheumatoid arthritis

Read More

Pentraxin-related protein PTX3 described as novel biomarker in advanced pancreatic cancer

Read More

Takeda begins phase III study of TAK-816 vaccine in Japan

Read More

Sunshine Biopharma and the Jewish General Hospital to collaborate on Adva-27a

Read More

National Eye Institute awards grant to Cedars-Sinai to develop stem cell therapies

Read More

LMS-611 obtains European orphan drug status in cystic fibrosis

Read More

Azellon to conduct phase I stem cell trial in the U.K. for meniscal tears

Read More

Wilex provides update on the Redectane approval process

Read More

Theratechnologies seeks approval for Egrifta in Canada

Read More

NovaBay and Alcon terminate Aganocides collaboration and license agreement

Read More

GTx begins phase IIb trial comparing Capesaris to Lupron Depot in advanced prostate cancer

Read More

FDA approves new 6-month formulation of Lupron Depot for advanced prostate cancer

Read More

Chelsea Therapeutics reports encouraging results from QTc interval study of Northera

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • 3D rendering of a molecular glue mediating the interaction between two proteins

    With surface mimicry, molecular glues shed hairpin need

    BioWorld Science
    Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe